Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03214250
Title Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Parker Institute for Cancer Immunotherapy
Indications

pancreatic adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel + Nivolumab

APX005M + Gemcitabine + Nab-paclitaxel

APX005M + Gemcitabine + Nab-paclitaxel + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.